These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16711766)

  • 21. QSAR study for a novel series of ortho monosubstituted phenoxy analogues of alpha1-adrenoceptor antagonist WB4101.
    Fumagalli L; Bolchi C; Colleoni S; Gobbi M; Moroni B; Pallavicini M; Pedretti A; Villa L; Vistoli G; Valoti E
    Bioorg Med Chem; 2005 Apr; 13(7):2547-59. PubMed ID: 15755656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiarrhythmic and α-Adrenoceptor Antagonistic Properties of Novel Arylpiperazine Derivatives of Pyrrolidin-2-one.
    Zaręba P; Dudek M; Lustyk K; Siwek A; Starowicz G; Bednarski M; Nowiński L; Zygmunt M; Sapa J; Malawska B; Kulig K
    Arch Pharm (Weinheim); 2015 Dec; 348(12):861-7. PubMed ID: 26523954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative structure activity relationship studies of aryl heterocycle-based thrombin inhibitors.
    Deswal S; Roy N
    Eur J Med Chem; 2006 Nov; 41(11):1339-46. PubMed ID: 16884829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, alpha 1-adrenoceptor antagonist activity, and SAR study of novel arylpiperazine derivatives of phenytoin.
    Handzlik J; Maciag D; Kubacka M; Mogilski S; Filipek B; Stadnicka K; Kieć-Kononowicz K
    Bioorg Med Chem; 2008 Jun; 16(11):5982-98. PubMed ID: 18490167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arylpiperazines with affinity toward alpha(1)-adrenergic receptors.
    Manetti F; Corelli F; Strappaghetti G; Botta M
    Curr Med Chem; 2002 Jul; 9(13):1303-21. PubMed ID: 12052168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computer--based drug design, synthesis and biological evaluation of new pyrimidinone derivatives linked to arylpiperazine and 2'-carbethoxy-biphenylylmethyl moeities as alpha1-adrenoceptor antagonists and angiotensin II AT1 receptor antagonists.
    Ismail MA; Abou El Ella DA; Abouzid KA; Al-Ansary GH
    Pharmazie; 2010 Nov; 65(11):794-800. PubMed ID: 21155384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.
    Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
    Eur J Med Chem; 2009 Oct; 44(10):3994-4003. PubMed ID: 19447527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computer modeling of size and shape descriptors of alpha 1-adrenergic receptor antagonists and quantitative structure-affinity/selectivity relationships.
    Montorsi M; Menziani MC; Cocchi M; Fanelli F; De Benedetti PG
    Methods; 1998 Mar; 14(3):239-54. PubMed ID: 9571081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, and alpha(1)-adrenoceptor binding properties of new arylpiperazine derivatives bearing a flavone nucleus as the terminal heterocyclic molecular portion.
    Betti L; Floridi M; Giannaccini G; Manetti F; Paparelli C; Strappaghetti G; Botta M
    Bioorg Med Chem; 2004 Mar; 12(6):1527-35. PubMed ID: 15018926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and biological evaluation of new arylpiperazine derivatives bearing a flavone moiety as α1-adrenoceptor antagonists.
    Jin J; Wang XB; Kong LY
    Bioorg Med Chem Lett; 2011 Feb; 21(3):909-11. PubMed ID: 21236664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
    Mandal AS; Roy K
    Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological affinity of new imidazo- and indol-arylpiperazine derivatives: further validation of a pharmacophore model for alpha(1)-adrenoceptor antagonists.
    Strappaghetti G; Mastrini L; Lucacchini A; Giannaccini G; Betti L; Fabbrini L
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5140-5. PubMed ID: 18760923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive quantitative structure-activity relationships (QSAR) analysis of beta 3-adrenergic ligands.
    Blin N; Federici C; Koscielniak T; Strosberg AD
    Drug Des Discov; 1995 Apr; 12(4):297-311. PubMed ID: 9040990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on novel pyridine and 2-pyridone derivatives of N-arylpiperazine as α-adrenoceptor ligands.
    Baran M; Kepczyńska E; Zylewski M; Siwek A; Bednarski M; Cegła MT
    Med Chem; 2014 Mar; 10(2):144-53. PubMed ID: 23627274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular modeling of histamine H3 receptor and QSAR studies on arylbenzofuran derived H3 antagonists.
    Dastmalchi S; Hamzeh-Mivehroud M; Ghafourian T; Hamzeiy H
    J Mol Graph Model; 2008 Jan; 26(5):834-44. PubMed ID: 17561422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. α-Adrenoceptor antagonistic and hypotensive properties of novel arylpiperazine derivatives of pyrrolidin-2-one.
    Zaręba P; Dudek M; Lustyk K; Siwek A; Starowicz G; Bednarski M; Nowiński L; Raźny K; Sapa J; Malawska B; Kulig K
    Bioorg Med Chem; 2015 May; 23(9):2104-11. PubMed ID: 25813897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative structure-activity relationship (QSAR) of aryl alkenyl amides/imines for bacterial efflux pump inhibitors.
    Nargotra A; Koul S; Sharma S; Khan IA; Kumar A; Thota N; Koul JL; Taneja SC; Qazi GN
    Eur J Med Chem; 2009 Jan; 44(1):229-38. PubMed ID: 18395941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fuzzy tricentric pharmacophore fingerprints. 2. Application of topological fuzzy pharmacophore triplets in quantitative structure-activity relationships.
    Bonachéra F; Horvath D
    J Chem Inf Model; 2008 Feb; 48(2):409-25. PubMed ID: 18254617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring QSTR and toxicophore of hERG K+ channel blockers using GFA and HypoGen techniques.
    Garg D; Gandhi T; Gopi Mohan C
    J Mol Graph Model; 2008 Feb; 26(6):966-76. PubMed ID: 17928249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3-Arylpiperazinylethyl-1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione derivatives as novel, high-affinity and selective alpha(1)-adrenoceptor ligands.
    Pittalà V; Romeo G; Salerno L; Siracusa MA; Modica M; Materia L; Mereghetti I; Cagnotto A; Mennini T; Marucci G; Angeli P; Russo F
    Bioorg Med Chem Lett; 2006 Jan; 16(1):150-3. PubMed ID: 16216506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.